Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  V.TLT.W | TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Bullboard Posts
Post by wildkydon Oct 07, 2019 4:25am
161 Views
Post# 30202292

Share Price

Share Price
I still blame the low share price on the inability of management to raise funds at a reasonable rate of dilution. The offering at .30 when we were comfortably sitting around .50 is absolutely criminal in my estimation. Obviously it opened the door for the vultures to drive the share price even lower. Now that being said, unless this process truly is a scam (which all of us here believe it is not) then one day the market and cancer stricken people will be clamoring for our product. Build it and they will come... The health system will want to use TLD-1433 because it will save money, the patients will want to use TLD-1433 because it will save their life without the sickening side effects of the current methods and the investors will want to invest in TLT because we will be making money. As the news slowly gets out, more and more people with cancer will want to learn more about our drug and as more people are successfully treated, they will spread the news of our miraculous cure! I also believe that as the word gets out that we have treated lung and brain cancer in the lab, that people with those diseases will be requesting to try TLD-1433 because nothing in the current system shows promise of freeing them from their death sentence. There will be more pressure on the FDA to fast track our treatment especially since information is spread so easily with the use of Google on the internet. The slow bureaucratic system is frustrating to no end, exemplified by the fact that 18 months went by without treating one person and I want to scream when another day goes by and thousands more people have died from cancer when we believe we have the cure for the deadliest disease on earth, yet no one seems to care!
Bullboard Posts